Articles On Cann Group (ASX:CAN)

The Althea Group Holdings Ltd (ASX: AGH) share price has been amongst the best performers on the Australian share market over the last 12 months. Since its 20 cents per share IPO in September of last year, the cannabis company’s shares hav...

With growing focus of governments across the globe on legalising recreational and medicinal cannabis, the cannabis industry is booming at a rapid pace and is expected to offer opportunities for investors. In 2016, Australia became the fourt...

Cannabis: An Overview The cannabis industry is booming at a rapid pace with governments across the globe creating the opportunities for investors by legalising recreational and medicinal cannabis. Legalisation of cannabis by government auth...

In afternoon trade the S&P/ASX 200 index has returned to form and is pushing higher once again. At the time of writing the benchmark index is up 0.5% to 6,473.4 points. Four shares climbing more than most today are listed below. Here’s...

Medicinal pot stock Cann Group (ASX:CAN) is planning to go large at its Mildura-based cannabis manufacturing facility. The company announced revised construction plans this morning which will see an extra production room added, along with d...

27 Aug 2019 - Cann Group (ASX:CAN) plans to increase production of its large-scale state-of-the-art greenhouse facility in Mildura.

The Cann Group Ltd (ASX: CAN) share price has been one of the best performers on the local share market on Tuesday. In morning trade the cannabis company’s shares are up over 12% to $1.92. Why is the Cann share price rocketing higher? Inve...

The increasing use of medical cannabis products has prompted many countries to soften the regulations regarding the manufacturing and consumption of cannabis products. Last year, Canada became the second and the largest country in the world...

‘Pot stocks’ were making headlines in 2018. California, one of the world’s biggest economies and the most populous state in the US, finally enacted legislation to legalise the recreational use of cannabis. It joined a growing list of US st...

Recently, Barbados, a Caribbean country, has introduced the Medicinal Cannabis Industry Act. If passed, it intends to open doors for the medicinal cannabis in the small country. Besides, the bill has proposed to set up a Licensing Authority...

Australia has established its strong position in the contemporary world that is welcoming the good side of cannabis with open arms, amid the recreational legalising debates. The country joined the bandwagon of Alaska, Canada, North Korea an...

Legalisation of Cannabis in Australia Cannabis is widely used for the remedies of Palliative care, Chronic non-cancer pain, Nausea and vomiting, Multiple sclerosis and many more chronic diseases. Before 2016, the production of cannabis was...

The Althea Group Holdings Ltd (ASX: AGH) share price is on course to start the month on a very positive note. In early afternoon trade on Thursday the cannabis company’s shares are up 5.5% to $1.11. Why is the Althea share price charging h...

Data analytics company Nielsen predicts that the American cannabis market will hit $US41 billion ($59.5 billion) by 2025 — a fivefold increase over 2018. While a good chunk of cannabis products are still illegal in the US, Nielsen reckons s...

The progress of the Australian medical cannabis industry since its legalisation indicates that the country is following the footsteps of Canada, attracting established international players. The market experts believe that the Australian ca...

The Cann Group Ltd  (ASX: CAN) share price could trade heavily this morning after the medicinal cannabis company announced its latest quarterly activities to the market. What did the Cann Group announce this morning? In its latest quarterl...

Cannabis can be understood as a nature-oriented medicine from the cannabis plants, used for medical as well as recreational purpose across the globe. Australia enjoys a long history in relation to the manufacturing of pharmaceutical grade m...

Australia’s pharmaceutical industry is innovative and immensely supports economic prosperity of the nation. The constituent companies not only provide treatments to save lives but also contribute to Australian economy by undertaking busines...

The Cann Group got manufacturing licenses for their facilities in Melbourne today, but their main focus will be on the Canadian market. We look at their valuation... The post Cann Group Share Price Up on Licence (ASX:CAN) appeared first on...

The company now holds all cultivation, production and manufacture licences under the Narcotics Drugs Act, along with import and export licences under the Customs Act.

The S&P/ASX 200 index has followed the lead of U.S. markets and dropped lower on Friday. At the time of writing the benchmark index is down 0.2% to 6,802.3 points. Four shares that haven’t let that hold them back are listed below. Here...

One of Australia’s leading cannabis developers, Cann Group (ASX: CAN) has been approved to manufacture cannabis products at its existing northern and southern medicinal cannabis facilities in Melbourne. The licences relate to the manufactur...

Australia’s cannabis industry continues to edge forward under the watchful eye of regulators. For now, it’s the Office of Drug Control’s world — and domestic cannabis companies just live in it. Scroll down for more ASX cannabis news >&gt...

26 Jul 2019 - Medicinal cannabis manufacturer and seller, Cann Group (ASX:CAN), has secured manufacturing licences from the Federal Department of Health’s Office of Drug Control fo…

Impression Healthcare (ASX: IHL) has tweaked its internal structure by appointing Dr Sud Agarwal, a leading figure in the medicinal cannabis industry as its Chief Medical Officer and non-executive director. The newly appointed executive is...

The Althea Group Holdings Ltd (ASX: AGH) share price has returned from its trading halt with a bang this morning. At the time of writing the cannabis company’s shares are up a sizeable 12% to $1.34. Why was Althea in a trading halt? Althea...

A new chain of medical cannabis clinics are set to roll out across Australia as part of a collaboration between Australian biopharma Zelda Therapeutics (ASX:ZLD) and Emerald Clinics. Zelda is developing a new cannabis-based treatment to red...

In this week’s recap of substantial holders, Australian Super became an substantial holder in Gage Roads Brewing (ASX: GRB), a prominent Sydney property magnate bought 16 per cent of Collaborate Corporation, and we look at a number of purch...

Pot stocks or cannabis related stocks are mushrooming in various parts of the world. In the recent times, Cannabis industry has witnessed a rise in the utilisation of cannabis for therapeutic purposes, post the legalisation of cannabis for...

Although it has given back its gains now, the Elixinol Global Ltd (ASX: EXL) share price was a strong performer this afternoon. At one stage the shares of the manufacturer and global distributor of industrial hemp based dietary supplement...

The Botanix Pharmaceuticals Ltd (ASX: BOT) share price has continued its impressive run and is up over 14% to 24 cents in morning trade. This means the clinical stage cannabinoid company’s shares have gained almost 250% since the start of...

Wth the legalisation of medical cannabis in many countries like Canada, the global medical cannabis industry has boomed quite a bit in recent times. Let’s take a quick look at 20 cannabis companies trading on ASX. Cann Group Limited (ASX:...

Like Really? Boxing legend Mike Tyson is developing his own marijuana holiday resort, the Tyson Ranch near Desert Hot Spring. The resort will include a music festival venue, a luxury hotel, the world’s longest lazy river, Tyson University a...

The Althea Group Holdings Ltd (ASX: AGH) share price has continued its positive run with another charge higher on Tuesday. The cannabis company’s shares were up as much as 12% to an all-time high of $1.13 at one stage. When its shares hit t...

Cannabis finds many applications in the medical field, where it helps in the formulation of drugs to ease out the pain of multiple sclerosis, enhance the effectiveness of treatment for hepatitis C with minimalistic side-effects, treat Parki...

Honey containing THC *might* be able to be exported and imported. The UK is the Next Big Thing in pot, Brexit or no. And 2020 is starting to look like a very hard deadline for a series of big events. There are 30 companies doing, or saying...

Honey containing THC *might* be able to be exported and imported. The UK is the Next Big Thing in pot, Brexit or no. And 2020 is starting to look like a very hard deadline for a series of big events. There are 30 companies doing, or saying...

Medical cannabis uses the marijuana plant or chemicals extracted from the plant for the treatment of diseases and symptoms, the plant (cannabis) possess over a hundred different chemicals called cannabinoids. There are a few forms of cannab...

From powdered milk to multivitamins to fresh fruit, Australian and New Zealand products command a health premium in Asian markets but can the medical cannabis industry leverage this 'clean green' image and follow suit?  Cann Group (ASX: C...

From powdered milk to multivitamins to fresh fruit, Australian and New Zealand products command a health premium in Asian markets but can the medical cannabis industry leverage this 'clean green' image and follow suit?  Cann Group (ASX: C...

The Cannabis sector is comparatively broad than the expectations of various market research houses, boutique research house or asset managers etc. The prevailing status of cannabis legalisation gradually appears positive, but the market wou...

Marijuana vs Liquor in the United States     Recent studies have revealed that the consumer demands in Cannabis and alcohol market space are not as correlated as was anticipated by the industry participants with the legalisation of marijuan...

Australian cinephiles have two silver screen shows made just for the cannabis crowd to watch. Feature-length film ‘High as Mike’ traces one Tamworth man’s difficult undertaking to access medical cannabis to treat his brain cancer. And the...

Australian cinephiles have two silver screen shows made just for the cannabis crowd to watch. Feature-length film ‘High as Mike’ traces one Tamworth man’s difficult undertaking to access medical cannabis to treat his brain cancer. And the...

One area of the share market that is performing better than most on Thursday is the cannabis industry. A number of cannabis-related shares are trading notably higher today. Two in particular that have caught the eye are listed below. Here’s...

Elixinol Global (ASX:EXL) has raised $50m from professional investors, making it the second largest capital raising among Australian pot stocks since Cann Group (ASX:CAN) took $60m in 2017 to build its growing facilities. Elixinol raised $4...

Despite IG Markets forcing its users to sell the 19 global pot stocks on its books by 24 May, Australian pot stocks have generally been racking up the good news. IG were spooked by potential legal ramifications, mostly affecting UK investor...